Rexulti is available in several dosage strengths to accommodate different patient needs and treatment regimens.
What are the available strengths of Rexulti?
Rexulti comes in tablet form with the following strengths: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg [1].
How is Rexulti prescribed for different conditions?
The starting and maximum recommended doses of Rexulti vary depending on the condition being treated. For adjunctive treatment of major depressive disorder (MDD) in adults, the starting dose is 1 mg once daily, which can be increased to 2 mg once daily. The maximum dose for MDD is 3 mg once daily [1].
For the treatment of schizophrenia in adults and pediatric patients 13 years and older, the starting dose is 1 mg once daily. Doses can be increased to 3 mg or 4 mg once daily, with the maximum recommended dose being 4 mg once daily [1].
For acute treatment of manic or mixed episodes associated with bipolar I disorder in adults and pediatric patients 13 years and older, the starting dose is 2 mg once daily. Doses can be adjusted in increments of 1 mg once daily to achieve the desired clinical effect. The maximum recommended dose is 6 mg once daily [1].
When does Rexulti patent protection expire?
Patent information for pharmaceuticals is dynamic and subject to various filings and challenges. For detailed and up-to-date patent expiry information for Rexulti, resources such as DrugPatentWatch.com can be consulted [2]. These resources track patent landscapes, including expiration dates and potential for generic competition.